These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1388 related articles for article (PubMed ID: 18329969)

  • 1. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
    Thelen A; Scholz A; Weichert W; Wiedenmann B; Neuhaus P; Gessner R; Benckert C; Jonas S
    Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
    Yeh TS; Tseng JH; Chen TC; Liu NJ; Chiu CT; Jan YY; Chen MF
    Hepatology; 2005 Sep; 42(3):657-64. PubMed ID: 16116640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
    Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
    J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
    Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
    Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
    J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
    Morimoto Y; Tanaka Y; Ito T; Nakahara M; Nakaba H; Nishida T; Fujikawa M; Ito T; Yamamoto S; Kitagawa T
    J Hepatobiliary Pancreat Surg; 2003; 10(6):432-40. PubMed ID: 14714164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.
    Zheng-Rong L; Hai-Bo Y; Xin C; Chuan-Xin W; Zuo-Jin L; Bing T; Jian-Ping G; Sheng-Wei L
    Am Surg; 2011 May; 77(5):627-33. PubMed ID: 21679599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.